Mona S. Jhaveri-Brown
Corporate Officer/Principal at National Cancer Institute
Profile
Mona S.
Jhaveri-Brown is Founder and Chief Executive Officer of Foligo Therapeutics, Inc. she is a Member of National Cancer Institute.
Dr. Jhaveri-Brown received a PhD in Biochemistry from Wake Forest University.
Mona S. Jhaveri-Brown active positions
Companies | Position | Start |
---|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 26/05/2009 |
Former positions of Mona S. Jhaveri-Brown
Companies | Position | End |
---|---|---|
Foligo Therapeutics, Inc.
Foligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Foligo Therapeutics, Inc. developed cancer therapeutics. The company was founded by Mona S. Jhaveri-Brown in April 11, 2006 and headquartered in Baltimore, MD. | Chief Executive Officer | - |
Training of Mona S. Jhaveri-Brown
Wake Forest University | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Foligo Therapeutics, Inc.
Foligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Foligo Therapeutics, Inc. developed cancer therapeutics. The company was founded by Mona S. Jhaveri-Brown in April 11, 2006 and headquartered in Baltimore, MD. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Stock Market
- Insiders
- Mona S. Jhaveri-Brown